Breaking barriers to novel analgesic drug development

Acute and chronic pain complaints, while very common, are generally poorly served by existing therapies. The unmet clinical need reflects the failure in developing novel classes of analgesics with superior efficacy, diminished adverse effects and a lower abuse liability than those currently availabl...

Full description

Saved in:
Bibliographic Details
Published in:Nat Rev Drug Discov
Main Authors: Yekkirala, Ajay S, Roberson, David P, Bean, Bruce P., Woolf, Clifford J.
Format: Artigo
Language:Inglês
Published: 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5675565/
https://ncbi.nlm.nih.gov/pubmed/28596533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrd.2017.87
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items